サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1568116

乳房再建の世界市場

Breast Reconstruction
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 272 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
乳房再建の世界市場
出版日: 2024年10月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 272 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

乳房再建の世界市場は2030年までに10億米ドルに達する見込み

2023年に6億9,290万米ドルと推定される乳房再建の世界市場は、分析期間2023-2030年にCAGR 5.6%で成長し、2030年には10億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである乳房インプラントは、CAGR 7.1％を記録し、分析期間終了時には6億2,950万米ドルに達すると予測されます。組織拡張器（Tissue Expanders）セグメントの成長率は、分析期間中CAGR 4.1％と推定されます。

米国市場は1億8,880万米ドルと推定、中国はCAGR9.4％で成長予測

米国の乳房再建市場は、2023年に1億8,880万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 9.4%で推移し、2030年には2億1,790万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1%と5.7%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の乳房再建市場- 主要動向と促進要因のまとめ

なぜ乳房再建ががん後の回復に不可欠なのか？

乳房再建は、乳がんのために乳房切除術や乳腺腫瘤摘出術を受けた女性にとって、乳房の形や見た目を回復させるのに欠かせない外科手術です。多くの人にとって、乳房再建は感情的・心理的なメリットをもたらし、がん治療後の自己意識とボディイメージの向上に貢献します。乳がんは世界中の女性の間で最も一般的ながんの一つであり、再建手術の需要は増加傾向にあります。自己組織フラップや高品質のインプラントの使用など、手術技術や材料の進歩により、乳房再建手術はより安全で効果的なものとなり、個々の患者のニーズに対応した、よりカスタマイズ可能なものとなった。

技術革新は乳房再建施術をどのように変えていますか？

乳房再建の技術的進歩は、患者の治療成績と手技の効率を著しく向上させています。より自然なテクスチャーや形状を含む、先進的な乳房インプラントの開発は、この分野に革命をもたらしました。さらに、3D画像技術の使用により、外科医はより精度の高い手術計画を立てることができるようになり、患者に期待される結果をより明確に提供することができるようになりました。患者自身の脂肪組織を使って乳房を再建する脂肪移植法も、従来のインプラントに代わる、より自然な方法として人気を集めています。さらに、ロボット支援手術の統合は、再建手術の精度を高め、患者の回復時間と合併症を軽減しています。

乳房再建機器を管理する規制・安全基準は？

規制基準は、乳房再建機器、特にインプラントや手術器具の安全性と有効性を確保する上で重要な役割を果たしています。米国では、FDAが乳房インプラントの承認と規制を監督し、安全性と品質基準を満たすために厳しい臨床試験を義務づけています。欧州では、CEマークがインプラントが健康、安全、環境保護基準に適合していることを証明する役割を果たしています。さらに、インプラントの破裂、被膜拘縮、または有害な免疫反応などの長期的な合併症を監視するために、継続的な監視および報告システムが実施されています。こうした規制の枠組みを遵守することは、メーカーやヘルスケアプロバイダーが信頼を維持し、患者に安全な再建の選択肢を提供するために不可欠です。

乳房再建市場の成長を促進する要因は？

乳房再建市場の成長は、乳がん罹患率の上昇、再建技術の進歩、乳房切除後の選択肢に対する意識の高まりなど、いくつかの要因によって牽引されています。乳がんの発見率が向上し生存率が高まるにつれて、治療後の生活の質を高めるために再建手術を選択する女性が増えています。シリコンインプラントや脂肪移植法の開発などの技術革新は、よりカスタマイズ可能で自然な仕上がりを提供し、患者の満足度を高めています。さらに、再建手術に対する認識とアクセシビリティの向上が、有利な保険政策と相まって、より多くの女性にこれらの選択肢を模索することを促し、市場の成長に寄与しています。

調査対象企業の例（注目の35社）

  • AbbVie, Inc.
  • Allergan Aesthetics
  • Establishment Labs S.A.
  • GC Aesthetics
  • GROUPE SEBBIN SAS
  • HansBiomed Co., Ltd.
  • Ideal Implant Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KOKEN CO., LTD.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24699

Global Breast Reconstruction Market to Reach US$1.0 Billion by 2030

The global market for Breast Reconstruction estimated at US$692.9 Million in the year 2023, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$629.5 Million by the end of the analysis period. Growth in the Tissue Expanders segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$188.8 Million While China is Forecast to Grow at 9.4% CAGR

The Breast Reconstruction market in the U.S. is estimated at US$188.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$217.9 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Breast Reconstruction Market - Key Trends & Drivers Summarized

Why Is Breast Reconstruction Crucial for Post-Cancer Recovery?

Breast reconstruction is a vital surgical procedure for women who have undergone mastectomy or lumpectomy due to breast cancer, helping restore the shape and appearance of the breast. For many, breast reconstruction offers emotional and psychological benefits, contributing to their sense of self and body image after cancer treatment. With breast cancer being one of the most common cancers among women worldwide, the demand for reconstructive surgeries is on the rise. Advancements in surgical techniques and materials, such as the use of autologous tissue flaps and high-quality implants, have made breast reconstruction procedures safer, more effective, and more customizable, catering to individual patient needs.

How Are Technological Innovations Transforming Breast Reconstruction Procedures?

Technological advancements in breast reconstruction are significantly improving patient outcomes and procedural efficiency. The development of advanced breast implants, including those with more natural textures and shapes, has revolutionized the field. In addition, the use of 3D imaging technology allows surgeons to plan surgeries with greater precision, providing patients with a clearer idea of expected results. Fat grafting techniques, which involve using the patient’s own fat tissue to rebuild the breast, are also gaining popularity as a more natural alternative to traditional implants. Furthermore, the integration of robotic-assisted surgery is enhancing the accuracy of reconstruction procedures, reducing recovery times and complications for patients.

What Regulatory and Safety Standards Govern Breast Reconstruction Devices?

Regulatory standards play a crucial role in ensuring the safety and efficacy of breast reconstruction devices, particularly implants and surgical tools. In the U.S., the FDA oversees the approval and regulation of breast implants, requiring rigorous clinical testing to ensure they meet safety and quality standards. In Europe, the CE mark serves as a certification that the implants comply with health, safety, and environmental protection standards. Additionally, ongoing surveillance and reporting systems are in place to monitor long-term complications such as implant rupture, capsular contracture, or adverse immune reactions. Compliance with these regulatory frameworks is essential for manufacturers and healthcare providers to maintain trust and provide patients with safe reconstruction options.

What Factors Are Driving the Growth of the Breast Reconstruction Market?

The growth in the breast reconstruction market is driven by several factors, including the rising incidence of breast cancer, advancements in reconstructive techniques, and increasing awareness of post-mastectomy options. As breast cancer detection rates improve and survival rates increase, more women are opting for reconstruction surgeries to enhance their quality of life post-treatment. Technological innovations, such as the development of silicone implants and fat grafting techniques, are providing more customizable and natural-looking results, increasing patient satisfaction. Additionally, greater awareness and accessibility to reconstructive surgery, combined with favorable insurance policies, are encouraging more women to explore these options, contributing to the market's growth.

Select Competitors (Total 35 Featured) -

  • AbbVie, Inc.
  • Allergan Aesthetics
  • Establishment Labs S.A.
  • GC Aesthetics
  • GROUPE SEBBIN SAS
  • HansBiomed Co., Ltd.
  • Ideal Implant Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KOKEN CO., LTD.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Breast Reconstruction - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Breast Cancer and Rise in Mastectomy Rates Drive Demand for Breast Reconstruction Procedures
    • Advancements in Implant Technology and Materials Propel Adoption of Modern Breast Reconstruction Implants
    • Growing Popularity of Autologous Tissue Reconstruction Techniques Strengthens Market Demand for Advanced Surgical Options
    • Expansion of Oncoplastic Surgery Techniques Creates New Growth Opportunities in Breast Reconstruction Procedures
    • Increasing Focus on Patient-Centered Care Drives Demand for Customized and Natural-Looking Breast Reconstruction Solutions
    • Rising Adoption of 3D Imaging and Surgical Planning Tools Enhances Precision and Outcomes in Breast Reconstruction Procedures
    • Growing Demand for Minimally Invasive Reconstruction Techniques Expands Market Applications in Diverse Patient Populations
    • Emergence of Bioengineered Implants and Regenerative Tissue Technologies Propels Innovation in Breast Reconstruction Solutions
    • Growing Focus on Psychological and Aesthetic Outcomes Strengthens Market for Post-Mastectomy Breast Reconstruction
    • Increasing Role of Robotic-Assisted Techniques in Breast Reconstruction Surgery Drives Technological Advancements
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Breast Reconstruction Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Breast Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Breast Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Breast Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Breast Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tissue Expanders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Tissue Expanders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Tissue Expanders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Acellular Dermal Matrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Acellular Dermal Matrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Acellular Dermal Matrix by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cosmetology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cosmetology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Breast Reconstruction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Breast Reconstruction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Breast Reconstruction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Breast Reconstruction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION